Adlercreutziaequolifaciens is a commensal bacterium isolated in Japan in 2008
Presence of Adlercreutzia is strongly correlated with the switch from NAFLD to NASH
Associated with “healthy” status while it disappears in cirrhotics
Reduces inflammation, decreases hyperglycemia and limits weight gain
in in vivo models transplanted with NASH patient microbiota and force-fed with a high fat, high fructose diet